GL9.IR Glanbia plc (EURONEXT) intraday EUR 16.68 20 Feb 2026: earnings due Feb 25

GL9.IR stock is trading at EUR 16.68 intraday on EURONEXT as markets position for Glanbia plc’s earnings due 25 Feb 2026 (16:30 UTC). Volume today is elevated at 1,191,043 shares versus an average of 422,848, signalling higher investor attention ahead of the report. We focus on margins, EPS and guidance because these metrics will likely drive a short-term re-rating. Meyka AI provides this data-driven preview to help assess whether the upcoming results justify current valuation.

Earnings snapshot: GL9.IR stock set for 25 Feb report

Glanbia plc (GL9.IR) reports results on 25 Feb 2026 and the market is watching for margin recovery and EPS guidance. The company’s next announcement follows a period where the stock traded between a 52-week low of EUR 9.20 and a high of EUR 17.20, with the current intraday price at EUR 16.68.

Short-term trading shows a relative volume of 2.81, indicating higher than normal activity. Investors should expect the company to address near-term pricing, input-cost trends and any guidance revisions that could move the stock on the day.

Fundamentals and valuation for GL9.IR stock

Glanbia’s trailing EPS is EUR 0.40, putting the current PE at 41.70, well above the Consumer Defensive sector average PE of 24.16. Book value per share is EUR 6.76 and price-to-book is 2.47, signalling a premium multiple versus tangible equity.

Key cash metrics include free cash flow per share EUR 1.15, a dividend per share of EUR 0.41 and a payout ratio near 94.58%. Market cap stands at EUR 4,044,073,806.00. These figures frame the earnings sensitivity: modest EPS beats could justify the multiple, while weak guidance would pressure the multiple down quickly.

Technical and trading signals for GL9.IR stock

Technicals show constructive momentum heading into earnings. The RSI is 63.14, ADX is 39.74 indicating a strong trend, and price sits near the middle Bollinger band (middle EUR 16.53, upper EUR 17.27). The 50-day average is EUR 15.40 and the 200-day average is EUR 14.06, supporting recent strength.

Intraday volume is 1,191,043 vs average 422,848, and the On-Balance Volume is negative but improving. These signals suggest the market is positioning for an earnings-driven move rather than a steady drift.

Meyka AI rates GL9.IR with a score out of 100 and analyst context

Meyka AI rates GL9.IR with a score of 70.39 out of 100 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating balances strong cash conversion and brand portfolio against a high PE and recent earnings weakness.

Independent broker consensus is limited in public sources; DCF signals are constructive while PE-based screens flag valuation risk. These mixed signals explain our B+ grade and the emphasis on the upcoming earnings print as a catalyst.

Price forecast and targets for GL9.IR stock

Meyka AI’s forecast model projects a quarterly target of EUR 17.24, a monthly view of EUR 12.91, and a one-year projection of EUR 11.19. Compared with the current price EUR 16.68, the quarterly model implies an upside of +3.41% and the one-year model implies a downside of -32.90%. Forecasts are model-based projections and not guarantees.

For scenario planning we set a short-term price target range: conservative EUR 15.00, base EUR 17.50, bull EUR 19.50. These targets reflect the 50/200-day trend, free cash flow yield of 7.33%, and sector multiples. Use the upcoming EPS and margin commentary to adjust positioning.

Earnings catalysts, risks and what to watch for GL9.IR stock

Catalysts include margin expansion in Nutrition & Ingredients, better wholesale channel mix for sports nutrition brands, and any positive guidance upgrade. Watch for commentary on raw-material costs, FX exposure, and consumer demand trends across Europe and North America.

Risks are high valuation sensitivity, near-term margin pressure, and payout sustainability given a payout ratio of 0.95. Competitor moves and packaged foods sector trends will also influence post-earnings reaction. For more background, compare historical data and peer sets Investing.com historical data and Investing.com competitor comparison. See our GL9.IR profile on Meyka for live updates: Meyka GL9.IR page.

Final Thoughts

Key takeaway: GL9.IR stock trades at EUR 16.68 intraday on EURONEXT with elevated volume as investors prepare for Glanbia’s 25 Feb 2026 earnings. The market will focus on margin trends and forward guidance because the current PE of 41.70 embeds high expectations. Meyka AI’s near-term model projects EUR 17.24 (implied +3.41%) while the one-year model is EUR 11.19 (implied -32.90%); forecasts are model-based projections and not guarantees. Our B+ score reflects solid cash generation and brand strength offset by valuation and recent earnings volatility. For traders, the earnings print can trigger a quick re-rating. For investors, use earnings detail on margins and free cash flow to decide whether to hold toward the base target EUR 17.50 or trim exposure if guidance weakens. Remember this analysis is informational and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.